Zusammenfassung
Die melanozytären Nävi stellen die häufigste Subgruppe der Nävi dar. Für gewöhnliche erworbene melanozytäre Nävi spielen genetische Disposition und UV-Exposition (UV: ultraviolette Strahlung) eine zentrale Rolle, sodass eine adäquate Aufklärung über Sonnenschutz vordringlich ist. Kongenitale melanozytäre Nävi (KMN) weisen in Abhängigkeit von ihrer Größe Besonderheiten in Diagnostik und Therapie auf. Kleine und mittelgroße KMN haben ein geringes malignes Potenzial; Melanome entstehen darauf selten und erst im Erwachsenenalter. Bei großen KMN steigt mit zunehmender Größe auch das Melanomrisiko; bei Riesennävi wird es mit maximal 10% beziffert. Zudem besteht bei Lokalisation an Kopf und Rücken die Gefahr einer neurokutanen Melanozytose, insbesondere beim Vorliegen von Satellitennävi. Die Therapie erworbener und kongenitaler Nävi ist immer individuell, sie richtet sich nach Art, Größe, Lokalisation, Patientenalter und subjektiver Beeinträchtigung und beinhaltet unterschiedliche operative Maßnahmen oder bei fehlendem Malignitätsverdacht zumeist nur die regelmäßige klinische Kontrolle. Blauer Nävus, Halo- oder Spitz-Nävus sind besondere Varianten melanozytärer Nävi, die ebenfalls kurz besprochen werden.
Abstract
Melanocytic nevi are the most common type of nevi. Genetic predisposition and exposure to UV light are especially relevant for the development of common acquired melanocytic nevi so that education about sun protection is of outstanding importance. Congenital melanocytic nevi (CMN) possess some peculiarities depending on nevus diameter. Small and medium-sized CMN bear a minor risk of developing melanoma in later life. The malignant potential of large CMN corresponds to their size and is estimated to be maximally 10% for giant CMN. Moreover, large and giant nevi on the head or trunk may be associated with neurocutaneous melanocytosis – especially if satellite nevi are present. Treatment of acquired and congenital melanocytic nevi is adjusted to individual needs and depends on nevus subtype, size, body site and patient age as well as subjective discomfort. Treatment options include surgery or regular clinical follow-up in cases of unworrisome presentation. Distinct subtypes of melanocytic nevi such as blue nevus, halo nevus or Spitz nevus are also shortly discussed.
Literatur
Argenziano G, Catricala C, Ardigo M et al (2011) Dermoscopy of patients with multiple nevi: improved management recommendations using a comparative diagnostic approach. Arch Dermatol 147:46–49
Barkovich AJ, Frieden IJ, Williams ML (1994) MR of neurocutaneous melanosis. AJNR Am J Neuroradiol 15:859–867
Bauer J, Garbe C (2004) Risk estimation for malignant transformation of melanocytic nevi. Arch Dermatol 140:127
Bauer J, Buttner P, Wiecker TS et al (2005) Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. Int J Cancer 116:755–761
Blokx WA, Dijk MC van, Ruiter DJ (2010) Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspects. Histopathology 56:121–132
Changchien L, Dusza SW, Agero AL et al (2007) Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic nevi. Arch Dermatol 143:1007–1014
Hale EK, Stein J, Ben Porat L et al (2005) Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi – results from the NYU-LCMN registry. Br J Dermatol 152:512–517
Happle R (1995) What is a nevus? A proposed definition of a common medical term. Dermatology 191:1–5
Harrison SL, MacKie RM, MacLennan R (2000) Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst 92:1436–1438
Heffel DF, Thaller S (2005) Congenital melanosis: an update. J Craniofac Surg 16:940–944
Kinsler VA, Aylett SE, Coley SC et al (2001) Central nervous system imaging and congenital melanocytic naevi. Arch Dis Child 84:152–155
Kinsler VA, Chong WK, Aylett SE et al (2008) Complications of congenital melanocytic naevi in children: analysis of 16 years experience and clinical practice. Br J Dermatol 159:907–914
Koot HM, Waard-van der Spek de, Peer CD et al (2000) Psychosocial sequelae in 29 children with giant congenital melanocytic naevi. Clin Exp Dermatol 25:589–593
Krengel S (2005) Nevogenesis – new thoughts regarding a classical problem. Am J Dermatopathol 27:456–465
Krengel S, Hauschild A, Schafer T (2006) Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 155:1–8
Krengel S, Breuninger H, Hauschild A et al (2008) Installation of a network for patients with congenital melanocytic nevi in German-speaking countries. J Dtsch Dermatol Ges 6:204–208
Krengel S, Breuninger H, Beckwith M et al (2011) Meeting report from the 2011 international expert meeting on large congenital melanocytic nevi and neurocutaneous melanocytosis, Tuebingen. Pigment Cell Melanoma Res 24:E1–6
Mahe E, Beauchet A, Paula CM de et al (2011) Outdoor sports and risk of UV-related skin lesions in children: evaluation of risks, and prevention. Br J Dermatol 165:360–367
Makkar HS, Frieden IJ (2004) Neurocutaneous melanosis. Semin Cutan Med Surg 23:138–144
Marghoob AA, Schoenbach SP, Kopf AW et al (1996) Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 132:170–175
Marghoob AA, Dusza S, Oliveria S et al (2004) Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 140:171–175
Puzenat E (2010) Photoprotection and children: why and how? Arch Pediatr 17:914–915
Siskind V, Hughes MC, Palmer JM et al (2011) Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 131:461–467
Stierman SC, Tierney EP, Shwayder TA (2009) Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature. Pediatr Dermatol 26:414–424
Streams BN, Lio PA, Mihm MC et al (2004) A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal. J Am Acad Dermatol 50:789–792
Tromberg J, Bauer B, Benvenuto-Andrade C et al (2005) Congenital melanocytic nevi needing treatment. Dermatol Ther 18:136–150
Wiecker TS, Luther H, Buettner P et al (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 97:628–638
Zaal LH, Mooi WJ, Sillevis Smitt JH et al (2004) Classification of congenital melanocytic naevi and malignant transformation: a review of the literature. Br J Plast Surg 57:707–719
Zalaudek I, Guelly C, Pellacani G et al (2011) The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations. J Invest Dermatol 131:542–545
Zedek DC, McCalmont TH (2011) Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma. Clin Lab Med 31:311–320
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wobser, M., Hamm, H. Melanozytäre Nävi. Monatsschr Kinderheilkd 159, 1077–1084 (2011). https://doi.org/10.1007/s00112-011-2425-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-011-2425-3